National focus on the AIDS epidemic has-stimulated an urgent need to prevent our blood resources transmitting a multiplicity of blood-borne viruses (BBVs), including the human immunodeficiency virus (HIV), non-A, non-B hepatitis virus (NANBHVs), hepatitis B virus (HBV), cytomegalovirus (CMV), human T-cell leukemia virus (HTLV-I/II, variants of HIV, and several other viral agents whose importance has not been fully recognized. Assessment of adsorption for virus or chemical inactivation in the experimentally infected units of blood components and plasma products is envisaged by using HIV as a prototype in vitro cultures and viral gene detection by polymerase chain reaction (PCR).
|Vyas, Girish N; Stoddart, Cheryl A; Killian, M Scott et al. (2012) Derivation of non-infectious envelope proteins from virions isolated from plasma negative for HIV antibodies. Biologicals 40:15-20|
|Vyas, Girish N (2008) Participating in the evolution of transfusion medicine from a dispensary into a discipline. Transfus Med Rev 22:162-7|
|Rawal, B D; Davis, R E; Busch, M P et al. (1990) Dual reduction in the immunologic and infectious complications of transfusion by filtration/removal of leukocytes from donor blood soon after collection. Transfus Med Rev 4:36-41|
|Rawal, B D; Schwadron, R; Busch, M P et al. (1990) Evaluation of leukocyte removal filters modelled by use of HIV-infected cells and DNA amplification. Blood 76:2159-61|
|Rawal, B D; Busch, M P; Endow, R et al. (1989) Reduction of human immunodeficiency virus-infected cells from donor blood by leukocyte filtration. Transfusion 29:460-2|